Skip to main content
National News Desk
health

India’s bird flu fight gets a homegrown weapon: First indigenous vaccine against H5N1 developed

The Indian Express NationalBy Anand Mohan J
20 Nov 2026
Original: English
India’s bird flu fight gets a homegrown weapon: First indigenous vaccine against H5N1 developed
India’s bird flu fight gets a homegrown weapon: First indigenous vaccine against H5N1 developed
Visual Coverage
AI Synopsis & Key Briefing

10971805 Shivraj Singh Chouhan

Key Highlights & Official Takeaways
  • ✓10971805 Shivraj Singh Chouhan
  • ✓Scientists at the ICAR-National Institute of High Security Animal Diseases (NIHSAD) developed the vaccine, which is priced at just Rs 1-2 per dose.
  • ✓Announcing the proposed Rs 300-crore laboratory, he said NIHSAD had emerged as a symbol of India's scientific capabilities.
  • ✓The minister said 147.16 crore free vaccine doses had been administered against Foot and Mouth Disease under the National Animal Disease Control Programme.
Comprehensive News & Policy Report

In a significant breakthrough for India's animal health research, scientists at a Bhopal-based government institute developed the country's first indigenous vaccine against H5N1 — the highly pathogenic strain of avian influenza.

Union Agriculture Minister Shivraj Singh Chouhan dedicated the vaccine to the nation on Friday at a ceremony in Bhopal, where he also announced a Rs 300-crore state-of-the-art animal disease research laboratory. “This vaccine is an example of India's self-reliance.

Bird flu causes large-scale chicken deaths and huge economic losses for poultry farmers. The indigenous vaccine will strengthen bird flu control in India and protect chickens,” he said. Scientists at the ICAR-National Institute of High Security Animal Diseases (NIHSAD) developed the vaccine, which is priced at just Rs 1-2 per dose.

Its development is seen as a significant addition to India's indigenous vaccine research, potentially reducing dependence on external technologies and making disease prevention more accessible to poultry farmers. Announcing the proposed Rs 300-crore laboratory, he said NIHSAD had emerged as a symbol of India's scientific capabilities.

The new facility is expected to strengthen the country's infrastructure for researching high-risk animal pathogens and developing vaccines. Chouhan praised the commitment of the research team behind the H5N1 vaccine, which comprised Dr S Nagarajan, Dr Manoj Kumar, Dr C Tosh, Dr H V Murugkar, Dr Aniket Sanyal, Dr Senthil Kumar D, Dr Naveen Kumar and Dr Yogisharadhya R.

He noted they worked continuously for months under demanding biosafety protocols, foregoing weekends and holidays. The restrictions included stringent sanitisation procedures before and after laboratory work and avoiding keeping pets at home during the research period.

Chouhan highlighted the economic importance of animal health, saying livestock and poultry were essential sources of regular income for rural households. Citing government estimates, he said diseases such as Foot and Mouth Disease, Lumpy Skin Disease, Brucellosis and Peste des Petits Ruminants together caused annual losses of approximately Rs 56,000 crore.

The minister said 147.16 crore free vaccine doses had been administered against Foot and Mouth Disease under the National Animal Disease Control Programme. He also cited the development of the Lumpi-ProVacInd vaccine following the 2022 Lumpy Skin Disease outbreak.

Chouhan also used this occasion to attack the Congress party. Without naming Congress leader Rahul Gandhi, he said: “Those who go abroad and question the capabilities of the country's constitutional institutions, scientists, and military should see India's achievements.

The world should see today's self-reliant and developed India. We must not sin by underestimating the country's capabilities”. Anand Mohan J is an award-winning Senior Correspondent for The Indian Express, currently leading the...

Read More

Actionable Steps for Aspirants & Citizens
  • •Aspirants and citizens are advised to monitor official notices and circulars issued by The Indian Express National.
  • •Verify all prescribed eligibility criteria, cutoff dates, and authenticated document requirements prior to formal submissions.
  • •Track connected examination timetables, vacancy advisories, and administrative gazettes on SuchnaSetu.
Official Notice Specification
Issuing AuthorityThe Indian Express National
Topic CategoryHEALTH
JurisdictionAll India / National
Publication Date20 November 2026
Connected Government Jobs & Upcoming Exams
Active on SuchnaSetu
Official Source Attribution: The Indian Express National
View Publisher Source Link

SuchnaSetu provides verified civic and public policy reports based on official notices. Primary publication and copyright remain with the respective government authority or publisher.